Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche
- PMID: 36638937
- DOI: 10.1016/j.actbio.2023.01.009
Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche
Abstract
Tumor recurrence and metastasis still greatly limit the therapeutic efficiency on the majority of postoperative clinical cases. With the aim to realize more powerful treatment outcomes on postoperative malignant tumors, a sponge-like neutrophil membrane-coated nano-system (NM/PPcDG/D) was fabricated to inhibit tumor recurrence and metastasis by inhibiting the recruitment and functions of myeloid-derived suppressor cell (MDSCs), which reinforced anti-tumor immunity and also suppressed pulmonary metastasis by inhibiting the formation of pre-metastatic niche (PMN). Firstly, PPcDG/D nanoparticles (NPs) were formulated by the self-assembling and crosslinking of synthesized redox-responsive polymer (PPDG) with doxorubicin (DOX) loading in the nanocore (PPcDG/D), followed by coating with activated neutrophils membrane to fabricate biomimetic NM/PPcDG/D. The sponge-like NM/PPcDG/D not only showed obvious natural tropism to postoperative inflammatory site, but also inhibited the recruitment and functions of MDSCs, thus relieved MDSCs-mediated immunosuppression. Additionally, NM/PPcDG/D also suppressed the formation of PMN to inhibit pulmonary metastasis by reducing the recruitment of MDSCs, decreasing the permeability of pulmonary vessels and inhibiting the implantation of circulating tumor cell (CTCs). Eventually, this fabricated NM/PPcDG/D NPs significantly inhibited tumor recurrence and metastasis on postoperative triple negative breast cancer (TNBC) model, presenting a promising therapeutic strategy on postoperative malignant tumors. STATEMENT OF SIGNIFICANCE: Myeloid-derived suppressor cells (MDSCs) play important roles in accelerating tumor recurrence and metastasis by promoting the establishment of immunosuppression in postoperative inflammatory regions and facilitating the formation of pulmonary pre-metastasis niche (PMN). In order to achieve enhanced suppression of recurrence and metastasis, a sponge-like NM/PPcDG/D nano-system was designed and fabricated. This nano-system is also the first attempt to integrate the regulation effects of a nano-sponge and anti-inflammatory agent to achieve enhanced multi-mode manipulation of MDSCs. Ultimately, NM/PPcDG/D powerfully restrained the recurrence and spontaneous metastasis on TNBC model. This article also revealed the particular roles of MDSCs involved in the regulation networks of postoperative recurrence and metastasis, immunosuppression and inflammation.
Keywords: Immunosuppression and inflammation; Membrane-coated nano-system; Myeloid-derived suppressor cells; Postoperative recurrence and metastasis; Pre-metastatic niche.
Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.Nano Lett. 2020 Apr 8;20(4):2219-2229. doi: 10.1021/acs.nanolett.9b03883. Epub 2019 Dec 11. Nano Lett. 2020. PMID: 31823615
-
Micellar nanoparticles inhibit the postoperative inflammation, recurrence and pulmonary metastasis of 4T1 breast cancer by blocking NF-κB pathway and promoting MDSCs depletion.Int J Pharm. 2022 Nov 25;628:122303. doi: 10.1016/j.ijpharm.2022.122303. Epub 2022 Oct 17. Int J Pharm. 2022. PMID: 36265660
-
Micellar nanoparticles inhibit breast cancer and pulmonary metastasis by modulating the recruitment and depletion of myeloid-derived suppressor cells.Nanoscale. 2022 Dec 1;14(46):17315-17330. doi: 10.1039/d2nr03880c. Nanoscale. 2022. PMID: 36374496
-
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation.Front Immunol. 2019 Feb 7;10:172. doi: 10.3389/fimmu.2019.00172. eCollection 2019. Front Immunol. 2019. PMID: 30792719 Free PMC article. Review.
-
Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.J Cell Physiol. 2018 Apr;233(4):3024-3036. doi: 10.1002/jcp.26075. Epub 2017 Aug 3. J Cell Physiol. 2018. PMID: 28661031 Review.
Cited by
-
Convergence of nanomedicine and neutrophils for drug delivery.Bioact Mater. 2024 Jan 27;35:150-166. doi: 10.1016/j.bioactmat.2024.01.022. eCollection 2024 May. Bioact Mater. 2024. PMID: 38318228 Free PMC article.
-
Advances in targeting tumor microenvironment for immunotherapy.Front Immunol. 2024 Oct 3;15:1472772. doi: 10.3389/fimmu.2024.1472772. eCollection 2024. Front Immunol. 2024. PMID: 39421736 Free PMC article. Review.
-
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.Int J Nanomedicine. 2024 Jan 18;19:571-608. doi: 10.2147/IJN.S442877. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260239 Free PMC article. Review.
-
Nanotechnology Applications in Breast Cancer Immunotherapy.Small. 2024 Oct;20(41):e2308639. doi: 10.1002/smll.202308639. Epub 2023 Dec 21. Small. 2024. PMID: 38126905 Review.
-
Pre-metastatic niche: formation, characteristics and therapeutic implication.Signal Transduct Target Ther. 2024 Sep 25;9(1):236. doi: 10.1038/s41392-024-01937-7. Signal Transduct Target Ther. 2024. PMID: 39317708 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials